Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 20 | 2019 | 1284 | 2.830 |
Why?
|
| Leiomyoma | 10 | 2019 | 730 | 2.790 |
Why?
|
| Infertility | 6 | 2017 | 655 | 1.880 |
Why?
|
| Uterine Neoplasms | 8 | 2018 | 1513 | 1.810 |
Why?
|
| Ovulation Induction | 5 | 2017 | 274 | 1.460 |
Why?
|
| Live Birth | 9 | 2022 | 512 | 1.070 |
Why?
|
| Oocyte Donation | 2 | 2016 | 49 | 1.070 |
Why?
|
| Oocytes | 4 | 2018 | 1188 | 1.020 |
Why?
|
| Infertility, Female | 11 | 2022 | 788 | 0.960 |
Why?
|
| Pregnancy Rate | 11 | 2019 | 643 | 0.890 |
Why?
|
| Myometrium | 4 | 2018 | 181 | 0.850 |
Why?
|
| Anti-Mullerian Hormone | 4 | 2022 | 402 | 0.820 |
Why?
|
| MicroRNAs | 5 | 2018 | 3751 | 0.770 |
Why?
|
| Ovarian Follicle | 4 | 2022 | 248 | 0.750 |
Why?
|
| Ovary | 5 | 2022 | 981 | 0.730 |
Why?
|
| Embryo Transfer | 7 | 2016 | 510 | 0.700 |
Why?
|
| Insemination, Artificial | 2 | 2017 | 98 | 0.690 |
Why?
|
| Estradiol | 6 | 2015 | 2020 | 0.630 |
Why?
|
| Oocyte Retrieval | 6 | 2019 | 161 | 0.630 |
Why?
|
| Fertilization | 1 | 2018 | 196 | 0.610 |
Why?
|
| Fertility Agents | 1 | 2017 | 11 | 0.600 |
Why?
|
| Pregnancy Outcome | 10 | 2016 | 2795 | 0.580 |
Why?
|
| Ovulation | 2 | 2018 | 189 | 0.580 |
Why?
|
| Zygote | 1 | 2017 | 116 | 0.580 |
Why?
|
| Single Embryo Transfer | 1 | 2016 | 29 | 0.560 |
Why?
|
| Fallopian Tube Diseases | 1 | 2016 | 62 | 0.540 |
Why?
|
| Endometriosis | 3 | 2014 | 839 | 0.510 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 435 | 0.510 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 139 | 0.490 |
Why?
|
| Spermatozoa | 1 | 2018 | 625 | 0.490 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 1200 | 0.490 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2023 | 370 | 0.440 |
Why?
|
| Cryopreservation | 5 | 2016 | 670 | 0.440 |
Why?
|
| Thyrotropin | 1 | 2016 | 849 | 0.420 |
Why?
|
| Abscess | 1 | 2016 | 607 | 0.420 |
Why?
|
| Pregnancy | 24 | 2022 | 29144 | 0.410 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 769 | 0.390 |
Why?
|
| Postmenopause | 2 | 2011 | 2460 | 0.370 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1741 | 0.370 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2012 | 440 | 0.360 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2017 | 1203 | 0.360 |
Why?
|
| Professional Practice | 1 | 2010 | 326 | 0.320 |
Why?
|
| Twinning, Monozygotic | 1 | 2007 | 17 | 0.310 |
Why?
|
| Waist Circumference | 1 | 2011 | 917 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8432 | 0.270 |
Why?
|
| Twins | 1 | 2007 | 339 | 0.270 |
Why?
|
| Female | 51 | 2023 | 380193 | 0.260 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2005 | 73 | 0.260 |
Why?
|
| Adipokines | 1 | 2007 | 320 | 0.260 |
Why?
|
| Leptin | 3 | 2007 | 1600 | 0.250 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 1344 | 0.250 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.240 |
Why?
|
| Physical Fitness | 1 | 2008 | 732 | 0.240 |
Why?
|
| Tissue Donors | 2 | 2003 | 2241 | 0.240 |
Why?
|
| Walking | 1 | 2011 | 1180 | 0.230 |
Why?
|
| Embryo Disposition | 1 | 2003 | 14 | 0.230 |
Why?
|
| Preservation, Biological | 1 | 2003 | 25 | 0.230 |
Why?
|
| Chorionic Villi | 1 | 2003 | 51 | 0.230 |
Why?
|
| Semen Preservation | 1 | 2003 | 35 | 0.230 |
Why?
|
| Embryo Implantation | 2 | 2016 | 272 | 0.220 |
Why?
|
| Fertility | 3 | 2017 | 781 | 0.220 |
Why?
|
| Cell Count | 4 | 2017 | 1856 | 0.220 |
Why?
|
| Body Mass Index | 2 | 2019 | 12721 | 0.210 |
Why?
|
| Adult | 30 | 2023 | 214052 | 0.200 |
Why?
|
| Body Composition | 1 | 2011 | 2402 | 0.200 |
Why?
|
| Adnexal Diseases | 1 | 2002 | 102 | 0.190 |
Why?
|
| Menopause | 1 | 2008 | 1626 | 0.190 |
Why?
|
| Body Weight | 1 | 2011 | 4671 | 0.180 |
Why?
|
| Chorionic Gonadotropin | 2 | 2012 | 476 | 0.180 |
Why?
|
| Acromegaly | 1 | 2023 | 347 | 0.180 |
Why?
|
| Premature Birth | 1 | 2012 | 1721 | 0.180 |
Why?
|
| Weight Loss | 1 | 2011 | 2625 | 0.180 |
Why?
|
| Humans | 49 | 2023 | 744366 | 0.170 |
Why?
|
| Cytokines | 1 | 2014 | 7323 | 0.170 |
Why?
|
| Ultrasonography | 3 | 2022 | 5984 | 0.170 |
Why?
|
| Hysterosalpingography | 1 | 2018 | 30 | 0.170 |
Why?
|
| Mediator Complex | 2 | 2015 | 109 | 0.160 |
Why?
|
| Birth Rate | 1 | 2019 | 170 | 0.160 |
Why?
|
| Vitrification | 2 | 2016 | 56 | 0.160 |
Why?
|
| Sperm Count | 1 | 2018 | 216 | 0.150 |
Why?
|
| Posthumous Conception | 2 | 2010 | 11 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2018 | 160 | 0.150 |
Why?
|
| Matched-Pair Analysis | 1 | 2018 | 288 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7182 | 0.150 |
Why?
|
| Sperm Motility | 1 | 2018 | 253 | 0.150 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1701 | 0.150 |
Why?
|
| Parity | 2 | 2022 | 929 | 0.150 |
Why?
|
| Climacteric | 1 | 2017 | 57 | 0.150 |
Why?
|
| Pregnancy Tests | 1 | 2017 | 30 | 0.150 |
Why?
|
| Uterus | 2 | 2014 | 711 | 0.150 |
Why?
|
| Semen Analysis | 1 | 2018 | 204 | 0.140 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2016 | 34 | 0.140 |
Why?
|
| Obesity | 3 | 2019 | 12746 | 0.140 |
Why?
|
| Menstrual Cycle | 2 | 2016 | 551 | 0.130 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2014 | 38 | 0.130 |
Why?
|
| Estrogens | 3 | 2017 | 1566 | 0.120 |
Why?
|
| Oogenesis | 1 | 2014 | 131 | 0.120 |
Why?
|
| Prevalence | 3 | 2017 | 15221 | 0.120 |
Why?
|
| Mullerian Ducts | 1 | 2014 | 198 | 0.120 |
Why?
|
| Syringes | 1 | 2013 | 56 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2016 | 9849 | 0.110 |
Why?
|
| Maternal Age | 1 | 2016 | 802 | 0.110 |
Why?
|
| Treatment Outcome | 10 | 2017 | 63107 | 0.110 |
Why?
|
| Menarche | 1 | 2015 | 516 | 0.110 |
Why?
|
| Retrospective Studies | 13 | 2023 | 77460 | 0.110 |
Why?
|
| Cell Line | 2 | 2018 | 16000 | 0.110 |
Why?
|
| Placenta | 1 | 2022 | 1699 | 0.110 |
Why?
|
| Reproductive Control Agents | 1 | 2012 | 7 | 0.110 |
Why?
|
| Infertility, Male | 1 | 2016 | 409 | 0.110 |
Why?
|
| Pregnancy, Ectopic | 1 | 2013 | 141 | 0.110 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2012 | 53 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2014 | 2441 | 0.100 |
Why?
|
| Aging | 2 | 2008 | 8664 | 0.100 |
Why?
|
| Insurance Coverage | 2 | 2016 | 1900 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 612 | 0.100 |
Why?
|
| Young Adult | 8 | 2022 | 56429 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 544 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 1222 | 0.100 |
Why?
|
| Age Distribution | 1 | 2017 | 2902 | 0.100 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 406 | 0.100 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 30 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 9735 | 0.090 |
Why?
|
| Logistic Models | 2 | 2016 | 13409 | 0.090 |
Why?
|
| Third-Party Consent | 1 | 2010 | 64 | 0.090 |
Why?
|
| Risk Factors | 6 | 2022 | 72296 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2016 | 2618 | 0.090 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 133 | 0.090 |
Why?
|
| Placenta Diseases | 1 | 2012 | 199 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 3511 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 20824 | 0.090 |
Why?
|
| Boston | 1 | 2022 | 9312 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3508 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2013 | 711 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6313 | 0.080 |
Why?
|
| Reproduction | 2 | 2023 | 668 | 0.080 |
Why?
|
| Breast | 1 | 2017 | 1970 | 0.080 |
Why?
|
| Birth Weight | 1 | 2016 | 2069 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 2850 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2007 | 23404 | 0.070 |
Why?
|
| Resistin | 1 | 2007 | 170 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2014 | 1826 | 0.070 |
Why?
|
| Diet | 2 | 2015 | 7937 | 0.070 |
Why?
|
| Estrone | 1 | 2007 | 240 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6489 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2014 | 21833 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2022 | 25628 | 0.070 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 385 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2022 | 53290 | 0.070 |
Why?
|
| Adolescent | 6 | 2019 | 85779 | 0.070 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 137 | 0.060 |
Why?
|
| Cyclins | 1 | 2007 | 603 | 0.060 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 744 | 0.060 |
Why?
|
| Prognosis | 3 | 2017 | 29060 | 0.060 |
Why?
|
| Fertility Agents, Female | 1 | 2005 | 99 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2760 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 18034 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2008 | 592 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.060 |
Why?
|
| Life Style | 1 | 2015 | 3835 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2007 | 671 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2016 | 7730 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2494 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 547 | 0.060 |
Why?
|
| Leuprolide | 1 | 2005 | 321 | 0.060 |
Why?
|
| Premenopause | 1 | 2007 | 1033 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2012 | 2052 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2725 | 0.050 |
Why?
|
| Mice | 8 | 2015 | 81201 | 0.050 |
Why?
|
| Tissue Banks | 1 | 2003 | 184 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 15078 | 0.050 |
Why?
|
| Adnexa Uteri | 1 | 2002 | 45 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10483 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3611 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.050 |
Why?
|
| Torsion Abnormality | 1 | 2002 | 93 | 0.050 |
Why?
|
| Marital Status | 1 | 2003 | 437 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2015 | 4285 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12244 | 0.050 |
Why?
|
| Male | 8 | 2022 | 350115 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4666 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 1486 | 0.050 |
Why?
|
| Inflammation | 2 | 2014 | 10637 | 0.040 |
Why?
|
| United States | 3 | 2017 | 69872 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4245 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5660 | 0.040 |
Why?
|
| Middle Aged | 5 | 2019 | 213390 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2023 | 441 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2007 | 2967 | 0.040 |
Why?
|
| Death | 1 | 2003 | 678 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1525 | 0.040 |
Why?
|
| Women's Health | 1 | 2007 | 2034 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 182 | 0.040 |
Why?
|
| Animals | 8 | 2015 | 168768 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2638 | 0.040 |
Why?
|
| Arteries | 1 | 2002 | 1119 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2029 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 2865 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 40075 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10183 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2009 | 3208 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2022 | 21748 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4424 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2110 | 0.030 |
Why?
|
| Quality of Life | 2 | 2014 | 12802 | 0.030 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2014 | 44 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2007 | 5023 | 0.030 |
Why?
|
| Motivation | 1 | 2003 | 1971 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2015 | 1386 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2008 | 4687 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.030 |
Why?
|
| Suction | 1 | 2013 | 267 | 0.030 |
Why?
|
| Meiosis | 1 | 2014 | 339 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.030 |
Why?
|
| Blastocyst | 1 | 2014 | 424 | 0.020 |
Why?
|
| Mesoderm | 1 | 2014 | 686 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2014 | 1185 | 0.020 |
Why?
|
| Progesterone | 1 | 2015 | 775 | 0.020 |
Why?
|
| Ethics Committees, Clinical | 1 | 2010 | 56 | 0.020 |
Why?
|
| beta Catenin | 1 | 2015 | 1059 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 16367 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2015 | 927 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1120 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 186 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1607 | 0.020 |
Why?
|
| Fibrosis | 1 | 2014 | 2029 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 4988 | 0.020 |
Why?
|
| Sirolimus | 1 | 2014 | 1565 | 0.020 |
Why?
|
| Ovum | 1 | 2007 | 189 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 2751 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2018 | 2150 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 599 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 361 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 463 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2575 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 163288 | 0.010 |
Why?
|
| Germ Cells | 1 | 2007 | 631 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1912 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8319 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1730 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2013 | 40559 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2010 | 1470 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 24252 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2375 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6386 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3505 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 5388 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12073 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 4410 | 0.010 |
Why?
|
| Child | 1 | 2002 | 77709 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39052 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14561 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 29786 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18373 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16690 | 0.010 |
Why?
|
Concepts
(255)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_